Standard antibiotics are failing against stubborn superbugs. Clinicians in Andhra Pradesh are deploying a microscopic hunter instead.
At SHRI Hospital in Guntur, infectious disease specialists have treated a select cohort of patients using bacteriophages—viruses that hunt, infect, and dissolve lethal bacterial strains while leaving human cells untouched. The early clinical results are positive.
Dr. Kalyan Chakravarthy Koganti, a sepsis and infectious disease specialist at SHRI Hospital, presented the team's data at an international scientific symposium organized jointly by the Chinese University of Hong Kong and peer-reviewed biomedical journals. The response from global microbiologists was immediate.
"Bacteriophages selectively target disease-causing bacteria without harming human beings," Dr. Chakravarthy stated, noting that these biological agents serve as targeted treatments when standard antibiotic regimens collapse.
Antimicrobial resistance poses an immediate threat to clinical medicine. Routine surgeries turn perilous when common bacteria survive every front-line drug on the shelf. Phages solve this by operating like guided missiles rather than broad-spectrum carpet bombs.
The initiative brings together hospital clinicians and university bench scientists. Dr. Sutharsan Govindarajan, an associate professor and phage biologist at SRM University AP, led the molecular research alongside Dr. Chakravarthy's clinical team. He delivered findings on phage architecture and therapeutic deployment directly to global specialists in Hong Kong.
The symposium was chaired by Professor Chuanbin Mao, a veteran researcher with 25 years dedicated to bacteriophage science and biological engineering. Sessions focused not only on resolving bloodstream infections, but also on using phages to detect complex diseases and deliver targeted cancer treatments.
| Research & Clinical Partner | Institutional Role | Key Contributor |
|---|---|---|
| SHRI Hospital (Guntur) | Sepsis & Inpatient Phage Administration | Dr. Kalyan Chakravarthy Koganti |
| SRM University AP | Phage Biology & Molecular Characterization | Dr. Sutharsan Govindarajan |
| Szeged University (Hungary) | International Translational Pipeline | Collaborative Research Faculty |
| Chinese University of Hong Kong | International Symposium Host | Prof. Chuanbin Mao (25-Yr Phage Specialist) |
Scaling the treatment is the next hurdle.
SHRI Hospital and SRM University AP have partnered with Hungary's Szeged University to build out laboratory capacity and import pipelines. The cross-border alliance is now mapping regulatory and logistical protocols to broaden patient access across India.